Dr. Mushlin's research focuses on the application of decision and cost-effectiveness analysis to the evaluation of clinical policies and medical technologies, with the aim of making medical care and public health more evidence-based and priority setting more rational. Specifically, he conducts studies to quantify the value and accuracy of diagnostic tests and procedures, understand the efficacy and cost-effectiveness of interventions for common clinical problems, and measure the quality of medical care. He is the author of over 100 publications in the fields of primary care, clinical epidemiology and medical technology assessment. He has been a consultant to many national groups, including the Clinical Efficacy Assessment Project of the American College of Physicians, the National Blue Cross Association and the United States Preventive Health Services Task Force.